Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Common Equity (2016 - 2026)

Lifevantage filings provide 15 years of Common Equity readings, the most recent being $33.0 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 10.37% to $33.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.0 million, a 10.37% increase, with the full-year FY2025 number at $34.6 million, up 33.28% from a year prior.
  • Common Equity hit $33.0 million in Q4 2025 for Lifevantage, down from $33.2 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $37.3 million in Q3 2021 to a low of $26.0 million in Q2 2024.
  • Median Common Equity over the past 5 years was $33.1 million (2025), compared with a mean of $32.2 million.
  • Biggest five-year swings in Common Equity: decreased 24.99% in 2024 and later skyrocketed 33.28% in 2025.
  • Lifevantage's Common Equity stood at $34.8 million in 2021, then decreased by 8.29% to $31.9 million in 2022, then dropped by 14.38% to $27.3 million in 2023, then increased by 9.46% to $29.9 million in 2024, then grew by 10.37% to $33.0 million in 2025.
  • The last three reported values for Common Equity were $33.0 million (Q4 2025), $33.2 million (Q3 2025), and $34.6 million (Q2 2025) per Business Quant data.